News
Turkish Cargo Has Been Carrying Turkish Rose Products to All Over the World for the Last Half Century
Possessing the world’s strongest cargo flight network and building the trade bridges between continents, Turkish Cargo also contributes greatly to Turkey’s exports. For over the last 60 years, Flag carrier air cargo brand has been carrying the rose products...
News
Vabiotech confirms production of first batch of Sputnik V vaccine in Vietnam
The Vietnamese pharmaceutical company Vabiotech confirmed on Wednesday the production of the first test batch of the Russian Sputnik V coronavirus vaccine at its facilities. Prior to that, the Russian Direct Investment Fund (RDIF) announced the start of production...
News
Genezen Appoints Vice President of Operations
Genezen Laboratories Inc. a cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has further strengthened its senior leadership team with the appointment of Brok Weichbrodt as Vice President of Operations.
Previously the Director of Commercial Operations at Catalent,...
News
Lonza and CN Bio Announce Distribution Agreement Providing Prevalidated Hepatocytes for Use on Innovative Organ-On-a-Chip Range
Lonza and CN Bio have entered into a distribution agreement whereby Lonza will supply a selection of hepatic cells to be prequalified by CN Bio for use in their PhysioMimix™ Single-and Multi-Organ MPS to transform the way human-relevant pre-clinical...
News
Xihua Scientific Selects LifeSphere MultiVigilance to Advance Pharmacovigilance Services
ArisGlobal, the leading provider of life sciences software that automates core drug development functions for over 300 life sciences companies, announced that Shanghai Xihua Scientific Co. Ltd., a fast-growing provider of late-phase drug research and development services for the...
Drug Research
Twist Bioscience Incorporates MOLCURE AI Technology to Augment Therapeutic Antibody Discovery
Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and MOLCURE Inc., announced they generated potent, binding antibodies to an undisclosed oncology target for Twist’s internal pipeline...
News
WuXi Biologics Received Commercial Manufacturing License from German Health Authorities for its German Drug Product Facility
WuXi Biologics, a global company with leading open-access biologics technology platforms, announced that it has received the License of Manufacturing Permit from German health authorities for its drug product facility (DP7) in Leverkusen, Germany. The permit successfully demonstrates for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















